Neuromuscular junction development

pathway activity — cross-omics
GO:0007528Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Neuromuscular junction development pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are NUF2, CRYM, and SPATA6L, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Neuromuscular junction development activity versus NUF2 in BRCA (Pearson r = -0.23).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCANUF2 →-1.097-0.779<.001<.00134
GBMCRYM →+1.549+1.372<.001<.00134
CCRCCSPATA6L →+0.780+0.699<.001<.00134
LSCCSPATA18 →+0.520+0.358<.001<.00134
OVARHGAP20 →+0.945+0.925<.001<.00133
OVCTNND1 →+0.446+0.653<.001<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0007528 vs NUF2 — BRCA

Per-sample scatter of Neuromuscular junction development activity vs NUF2 in BRCA.

Explore this scatter interactively →

Exploration